Dronabinol(Vertanical)

屈大麻酚(Vertanical)

Report date: 2026/03/14 20:00:17

Base Information

Drug NameDronabinol(Vertanical)
Drug Alias Namedelta-9-TetrahydrocannabinolVER-01VER-01
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionCannabinoid CB1 receptor agonistsCannabinoid CB2 receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsLow Back Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVertanical GmbH
China Registration ClassN/A

Develop Information

Active CompaniesVertanical GmbH
Inactive CompaniesN/A
Active IndicationsLow Back Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A